These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3327892)

  • 21. [Generally effective for unstable bladder? Tamsulosin: application not limited to benign prostatic hyperplasia].
    Urologe A; 2003 Feb; 42(2):301-2. PubMed ID: 12739514
    [No Abstract]   [Full Text] [Related]  

  • 22. Nicergoline in the treatment of dizziness in elderly patients. A review.
    Felisati G; Pignataro O; Di Girolamo A; Bruno E; Alessandrini M; Guidetti G; Monzani D; Beldi AM; Mira E; Benazzo M; Pallestrini E; Caligo G; Casani A; Battaglia A
    Arch Gerontol Geriatr Suppl; 2004; (9):163-70. PubMed ID: 15207410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neurophysiological study of 36 patients with cerebral vascular processes treated with nicergoline (author's transl)].
    Samsó Dies JM; Villa Badó J; Villalobos J; Iriarte JL; Ordeix R
    Arzneimittelforschung; 1979; 29(8a):1301-7. PubMed ID: 540075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Haemodynamic and metabolic effects of exercise test in diabetic patients with arteritis treated or not with nicergoline (author's transl)].
    Boismare F; Leclerc JL; Lefrançois J; Moore N; Paux G; Schrub JC; Vuillermet P
    Sem Hop; 1981 Sep 18-25; 57(33-36):1455-7. PubMed ID: 6270809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentiation by an alpha-adrenolytic agent, nicergoline, of the cardiac effects of propranolol.
    Boismare F; Moore N; Decourt S; Paux G; Saligaut C; Chretien P
    Methods Find Exp Clin Pharmacol; 1983; 5(2):83-8. PubMed ID: 6876944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapeutic trial in acute cochlear deafness. A comparative study of Ginkgo biloba extract and nicergoline].
    Dubreuil C
    Presse Med; 1986 Sep; 15(31):1559-61. PubMed ID: 2947099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Action of Nicergoline (Sermion) in chronic vascular disease in old age].
    Michelangeli J; Sevilla M; Lavagna J; Darcourt G
    Ann Med Psychol (Paris); 1975 Apr; 1(4):499-510. PubMed ID: 788599
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapeutic possibilities of nicergoline in neurogenic bladder dysfunction].
    Gallego Gómez J; Jiménez Cruz JF; Martínez Agulló E; Mompó Sanchís JA; Llopis Mínguez B; Boronat Tormo F
    Arch Esp Urol; 1985; 38(2):175-90. PubMed ID: 2862846
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effects of nicergoline on artificially induced micturition in the rabbit with and without prostatic hypertrophy].
    Richard O; Weber J; Moore N; Boismare F
    J Pharmacol; 1986; 17(4):664-70. PubMed ID: 2436010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Quantitative EEG examinations on the vigilance stabilizing effect of nicergoline / Results of a double blind study with gerontopsychiatric patients (author's transl)].
    Bente D; Glatthaar G; Ulrich G; Lewinsky M
    Arzneimittelforschung; 1979; 29(11):1804-8. PubMed ID: 543890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nicergoline in the treatment of neuropathic bladder dysfunction: a preliminary report.
    Gallego J; Forner V; Jimenez F; Martinez E
    Paraplegia; 1984 Aug; 22(4):216-24. PubMed ID: 6483464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical study on nicergoline in peripheral arteriopathies.
    Schönenberger F
    Farmaco Prat; 1976 Nov; 31(11):561-7. PubMed ID: 797575
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical and biochemical effects of nicergoline in chronic schizophrenic patients.
    Albus M; Botschev C; Müller-Spahn F; Naber D; Münch U; Ackenheil M
    Pharmacopsychiatry; 1986 May; 19(3):101-5. PubMed ID: 3725889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Benign prostatic syndrome. Urinary urgency and micturition frequency reduced with plant preparation].
    MMW Fortschr Med; 2005 Oct; 147(40):52-3. PubMed ID: 16255520
    [No Abstract]   [Full Text] [Related]  

  • 35. Contingent negative variation and reaction time in patients with presenile idiopathic cognitive decline and presenile Alzheimer-type dementia. Preliminary report on long-term nicergoline treatment.
    Zappoli R; Arnetoli G; Paganini M; Versari A; Battaglia A; Grignani A; Sacchetti G
    Neuropsychobiology; 1987; 18(3):149-54. PubMed ID: 3453431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of the effectiveness and tolerance of the preparation Sermion in the treatment of selected retinal diseases].
    Szaflik J; Jupowiecka A
    Klin Oczna; 1985 Apr; 87(4):165-6. PubMed ID: 3900547
    [No Abstract]   [Full Text] [Related]  

  • 37. [Double-blind randomized comparative study of nicergoline naftidrofuryl on the quality of life in chronic obliterative arteriopathy of lower limbs with intermittent claudication].
    Meilhac B; Montestruc F; Aubin F; Djian F; Rouffy J
    Therapie; 1997; 52(3):179-86. PubMed ID: 9366101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nicergoline and cerebral performance insufficiency. Observations in 1 year treatment controls].
    Kugler J; Heidrich H
    Fortschr Med; 1984 Nov; 102(42):1091-6. PubMed ID: 6392047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do alpha-blockers have a role in lower urinary tract dysfunction in multiple sclerosis?
    O'Riordan JI; Doherty C; Javed M; Brophy D; Hutchinson M; Quinlan D
    J Urol; 1995 Apr; 153(4):1114-6. PubMed ID: 7869476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical trial of a new vasoactive drug F.I. 6714 administered intra-arterially in peripheral vascular diseases].
    Masini G
    Minerva Cardioangiol; 1975 Feb; 23(2):120-5. PubMed ID: 1095956
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.